Template:Current week ecosystem agenda: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 1: Line 1:
  2021 Week 13
  2021 Week 14
 
*'''Apr-05 Mo'''
 
----
*'''Apr-06 Tu'''


*'''Mar-29 Mo'''
:{|
:{|
| width="110" align="center" | [[File:MITOEAGLE-representation.jpg|left|100px|link=http://www.mitoeagle.org/index.php/MitoEAGLE |COST Action MitoEAGLE]]
| width="110" align="center" | [[Image:O2k-Support.jpg|60px|link=http://wiki.oroboros.at/index.php/O2k-Open_Support |O2k-Open Support]] [[File:Red-loss of data.png|40px|Warning: loss of data]]
|''' [[MitoEAGLE#MitoEAGLE_dissemination |MitoEAGLE dissemination - did you receive your package?]]''' <br>
 
[https://www.bioenergetics-communications.org/index.php/bec/article/view/gnaiger_2020_mitophysiology Bioenergetics Communications - to enhance reproducibility in mitochondrial physiology]
| '''A damaged OroboPOS-Holder may cause medium to leak from the O2k-Chamber.'''<br>
<br>
 
- including: the »[https://wiki.oroboros.at/images/2/29/MitoPathways_Suppl_Poster_doi10.26124bec2020-0002.s1.jpg '''MitoEAGLE Poster''']« and »[https://www.bioenergetics-communications.org/index.php/bec/article/view/gnaiger_2020_mitopathways Mitochondrial pathways and respiratory control<br>
See how you can check that the OroboPOS-Holders are intact.<br>
- »[[O2k-OroboPOS-Holder_MitoPedia#O2k-OroboPOS-Holder:_Leaky_chamber_due_to_damaged_OroboPOS-Holder |'''O2k-OroboPOS-Holder''']]«
|}
|}
----
----
*'''Mar-30 Tu'''
*'''Apr-07 We'''


----
----
*'''Mar-31 We'''  
*'''Apr-08 Th'''  
:{|
::::[[Image:O2k-Publications.jpg|60px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]] Parkinson’s Disease Awareness Month:''' Dominant mutation in Parkinson’s Disease causes loss of protein function in mitochondria'''  
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
::::::: - from the O2k-Network »[[FR Angers Gueguen N]]« and »[[BE Leuven Spinazzi M]]«
|'''Diabetes, infarct size, mitochondrial respiration and succinate dehydrogenase inhibition - how do they relate?'''<br>
::::::* Cornelissen T, Spinazzi M, Martin S, Imberechts D, Vangheluwe P, Bird M, De Strooper B, Vandenberghe W (2020) CHCHD2 harboring the Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2. Hum Mol Genet [Epub ahead of print]. [[Cornelissen 2020 Hum Mol Genet|»Bioblast link«]]
:from the O2k-Network »[[DK Aarhus Boetker HE]]«  
----
*Tonnesen PT, Hjortbak MV, Lassen TR, Seefeldt JM, Bøtker HE, Jespersen NR (2021) Myocardial salvage by succinate dehydrogenase inhibition in ischemia-reperfusion injury depends on diabetes stage in rats. Mol Cell Biochem [Epub ahead of print].[[Tonnesen 2021 Mol Cell Biochem|»Bioblast link«]]
*'''Apr-09 Fr'''
|}
----
----
*'''Apr-1 Th'''  
 
:::: Abstract submission deadline for »[[SfRBM 2021 Virtual]]«
*'''Apr-10 Sa'''
----
----
*'''Apr-2 Fr''' - World Autism Awareness Day  
 
*'''Apr-11 Su''' - World Parkinson's Disease Day
 
:{|
:{|
| width="100" align="center" | [[File:O2k-brief.png|45px|link=http://wiki.oroboros.at/index.php/O2k-brief|O2k-brief repository]]
| width="100" align="center" | [[File:O2k-brief.png|45px|link=http://wiki.oroboros.at/index.php/O2k-brief|O2k-brief repository]]
|''' Impaired mitochondrial function correlates to autism endophenotypes in mice''' <br>
|'''Parkinson model with 6-hydroxydopamine shows brain-region specific mitochondrial bioenergetics''' <br>
:from the O2k-Network »[[DE Ulm Radermacher P]]« and »[[US PA Philadelphia Wallace DC]]«
:from the O2k-Network »[[BR Santa Maria Soares FA]]«


* Yardeni T, Cristancho AG, McCoy AJ, Schaefer PM, McManus MJ, Marsh ED, Wallace DC (2021) An mtDNA mutant mouse demonstrates that mitochondrial deficiency can result in autism endophenotypes. Proc Natl Acad Sci U S A 118:e2021429118.  [[Yardeni 2021 Proc Natl Acad Sci U S A|»Bioblast link«]]
*Gonçalves DF, Courtes AA, Hartmann DD, da Rosa PC, Oliveira DM, Soares FAA, Dalla Corte CL (2018) 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat. Neurotoxicology 70:1-11.  [[Goncalves 2018 Neurotoxicology|»Bioblast link«]]
|}
|}

Revision as of 08:30, 6 April 2021

2021 Week 14
  • Apr-05 Mo

  • Apr-06 Tu
O2k-Open Support Warning: loss of data A damaged OroboPOS-Holder may cause medium to leak from the O2k-Chamber.

See how you can check that the OroboPOS-Holders are intact.
- »O2k-OroboPOS-Holder«


  • Apr-07 We

  • Apr-08 Th
O2k-Publications in the MiPMap Parkinson’s Disease Awareness Month: Dominant mutation in Parkinson’s Disease causes loss of protein function in mitochondria
- from the O2k-Network »FR Angers Gueguen N« and »BE Leuven Spinazzi M«
  • Cornelissen T, Spinazzi M, Martin S, Imberechts D, Vangheluwe P, Bird M, De Strooper B, Vandenberghe W (2020) CHCHD2 harboring the Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2. Hum Mol Genet [Epub ahead of print]. »Bioblast link«

  • Apr-09 Fr

  • Apr-10 Sa

  • Apr-11 Su - World Parkinson's Disease Day
O2k-brief repository Parkinson model with 6-hydroxydopamine shows brain-region specific mitochondrial bioenergetics
from the O2k-Network »BR Santa Maria Soares FA«
  • Gonçalves DF, Courtes AA, Hartmann DD, da Rosa PC, Oliveira DM, Soares FAA, Dalla Corte CL (2018) 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat. Neurotoxicology 70:1-11. »Bioblast link«
Cookies help us deliver our services. By using our services, you agree to our use of cookies.